Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
OwnerHector DeLuca, Terrence Meehan +2inventors
InventorsHector DeLuca, Terrence Meehan, Bryan Becklund, Margaret Clagett-Dame
Life of this patent
Estimating the term…
Abstract
Methods for treating and preventing multiple sclerosis by administering to a patient an effective amount of calcitonin, calcitonin-like peptides or calcitonin mimetics to a patient. Additionally, 1,25-dihydroxyvitamin D analogs can be used in combination with the calcitonin, calcitonin-like peptides or calcitonin mimetics.
Claims18
A method for decreasing multiple sclerosis symptoms comprising the steps of
- (a) selecting a multiple sclerosis patient or patient in danger of multiple sclerosis, and
- (b) administering an amount of calcitonin, calcitonin-like peptide or calcitonin mimetic to the patient, wherein the amount is sufficient to diminish multiple sclerosis symptoms.
A pharmaceutical preparation comprising calcitonin, calcitonin-like-peptide or calcitonin mimetic combined with a 1,25-dihydroxyvitamin D analog in an amount effective to relieve multiple sclerosis symptoms.
Dependencies are inferred from the claim text.